Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer

@inproceedings{Wang2011EnhancingCR,
  title={Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian
                    Cancer},
  author={Enfeng Wang and Sanjib Bhattacharyya and Annam{\'a}ria Szabolcs and Cristian Rodriguez-Aguayo and Nicholas B. Jennings and Gabriel L{\'o}pez-Berestein and Priyabrata Mukherjee and Anil Sood and Resham Bhattacharya},
  booktitle={PloS one},
  year={2011}
}
Undoubtedly ovarian cancer is a vexing, incurable disease for patients with recurrent cancer and therapeutic options are limited. Although the polycomb group gene, Bmi-1 that regulates the self-renewal of normal stem and progenitor cells has been implicated in the pathogenesis of many human malignancies, yet a role for Bmi-1 in influencing chemotherapy response has not been addressed before. Here we demonstrate that silencing Bmi-1 reduces intracellular GSH levels and thereby sensitizes… CONTINUE READING
Highly Cited
This paper has 247 citations. REVIEW CITATIONS

7 Figures & Tables

Topics

Statistics

05010020112012201320142015201620172018
Citations per Year

247 Citations

Semantic Scholar estimates that this publication has 247 citations based on the available data.

See our FAQ for additional information.